Print Online Press - Recovery CNT

Edge Media Network : National Drug Take Back Day

Posted on May 9, 2017 by admin_cnt

EDGE, the largest network of local Lesbian, Gay Bisexual and Transgender (LGBT) news and entertainment publications in the world, serving metropolitan areas around the United States leverages Dr. Cidambi’s knowledge of Addiction to talk about the National Drug Take Back Day.

Why Doctors Are Diagnosing More Women With ADHD

Posted on May 8, 2017 by admin_cnt

Dr. Cidambi says a spike in ADHD prescriptions among reproductive age women could be because more women are turning to ADHD medications to obtain a high, as states clamp down on opioid pain pill prescriptions.

Talkbusiness.net : Opioids versus medical marijuana debate begins in Arkansas

Posted on May 5, 2017 by admin_cnt

Talk Business and Politics of Arkansas talks to Dr. Cidambi on the possibility of legalizing marijuana in the state.

Daily Record : LETTER- Decriminalize marijuana, don’t legalize it

Posted on April 9, 2017 by admin_cnt

Morris county’s leading news paper publishes Dr. Cidambi’s Op-Ed piece on the perils of legalizing marijuana for recreational use.

Hidden Testimony -Substance Abuse Among Attorneys

Posted on April 1, 2017 by admin_cnt

CNT’s Medical Director, Indra Cidambi, M.D. comments on the link between genetics and addiction.

Mixing “Benzos” With Opiates Will Cause A Drug Pandemic In America

Posted on April 1, 2017 by admin_cnt

CNT’s Medical Director, Indra Cidambi, M.D. comments on the link between genetics and addiction.

MyCentralJersey.com : Lt. Governor Kim Guandango tour center for network therapy

Posted on October 17, 2016 by admin_cnt

New Jersey’s Lt. Governor, Kim Guadagno, visited the Center for Network Therapy to understand the ambulatory Detox model and find out how CNT is able to address the needs of individuals suffering from opiate withdrawal, benzo withdrawal and alcohol withdrawal. She was impressed by the efficacy of the program.

Rehab Today : Now there’s an implant to treat opioid addiction . But will it really help people or create more problems?

Posted on October 17, 2016 by admin_cnt

Rehab Today, a leading web site that discussed addiction issues, sought Dr. Cidambi’s views on implantable buprenorphine, Probuphine. Dr. Cidambi detailed why she thinks the uptake of Probuphine will be much weaker than expected.

National Public Radio : Long-Acting Opioid Treatment Could Be Available In A Month

Posted on October 17, 2016 by admin_cnt

FDA recently announced the approval of Probuphine, an implantable form of buprenorphine, for treating opioid dependence. National Public Radio sought the views of Dr. Cidambi, addiction expert and medical director of the Center for Network Therapy, on the medication.

Dr. Oz The Good Life.com : The first implant for opioid addiction just recieved FDA approval

Posted on October 17, 2016 by admin_cnt

Dr. Oz’s online health site seeks addiction expert, Dr. Cidambi’s views on Probuphine, which was recently approved by the FDA. Probuphine is intended for treatment for opioid dependence and it is used to treat individuals suffering from opiate withdrawal and opiate cravings. Dr. Cidambi, Center for Network Therapy’s medical director argues why Probuphine will flop.